Skip to main content

Neurotoxic Consequences of Antiretroviral Therapies

  • Living reference work entry
  • First Online:

Antiretroviral Therapy (ART) and the Central Nervous System (CNS)

With the introduction of combination antiretroviral therapy (CART), also known as highly active antiretroviral therapy (HAART), for the control of human immunodeficiency virus (HIV) infection, it has been possible to suppress viral quantity in patients’ blood, often to undetectable levels. This intervention has decreased the overall HIV/AIDS disease burden and increased the life span of HIV-infected individuals. However, HIV reservoirs persist in tissue compartments where there is limited access of antiretroviral drugs and/or the presence of long-lived latent HIV reservoirs. Given these circumstances, the complete control of HIV replication and the eradication of HIV have been difficult and infected individuals must continue on treatment regimens indefinitely. Antiretroviral therapies (ARTs) are essential for the effective treatment of HIV infection, but these compounds also have intrinsic toxicity and with long-term...

This is a preview of subscription content, log in via an institution.

References

  • Akay C, Cooper M, Odeleye A, Jensen BK, White MG, et al. Antiretroviral drugs induce oxidative stress and neuronal damage in the central nervous system. J Neurovirol. 2014;20:39–53.

    Article  PubMed  CAS  PubMed Central  Google Scholar 

  • Ciccarelli N, Fabbiani M, Di Giambenedetto S, Fanti I, Baldonero E, et al. Efavirenz associated with cognitive disorders in otherwise asymptomatic HIV-infected patients. Neurology. 2011;76:1403–9.

    Article  PubMed  CAS  Google Scholar 

  • Cysique LA, Brew BJ. Neuropsychological functioning and antiretroviral treatment in HIV/AIDS: a review. Neuropsychol Rev. 2009;19:169–85.

    Article  PubMed  Google Scholar 

  • Evans SR, Ellis RJ, Chen H, Yeh TM, Lee AJ, et al. Peripheral neuropathy in HIV: prevalence and risk factors. AIDS. 2011;25:919–28.

    Article  PubMed  PubMed Central  Google Scholar 

  • Foster R, Olajide D, Everall IP. Antiretroviral therapy-induced psychosis: case report and brief review of the literature. HIV Med. 2003;4:139–44.

    Article  PubMed  CAS  Google Scholar 

  • Giunta B, Ehrhart J, Obregon DF, Lam L, Le L, et al. Antiretroviral medications disrupt microglial phagocytosis of beta-amyloid and increase its production by neurons: implications for HIV-associated neurocognitive disorders. Mol Brain. 2011;4:23.

    Article  PubMed  CAS  PubMed Central  Google Scholar 

  • Heaton RK, Franklin DR, Ellis RJ, McCutchan JA, Letendre SL, et al. HIV-associated neurocognitive disorders before and during the era of combination antiretroviral therapy: differences in rates, nature, and predictors. J Neurovirol. 2011;17:3–16.

    Article  PubMed  CAS  PubMed Central  Google Scholar 

  • Koczor CA, Lewis W. Nucleoside reverse transcriptase inhibitor toxicity and mitochondrial DNA. Expert Opin Drug Metab Toxicol. 2010;6:1493–504.

    Article  PubMed  CAS  Google Scholar 

  • Leeansyah E, Cameron PU, Solomon A, Tennakoon S, Velayudham P, et al. Inhibition of telomerase activity by human immunodeficiency virus (HIV) nucleos(t)ide reverse transcriptase inhibitors: a potential factor contributing to HIV-associated accelerated aging. J Infect Dis. 2013;207:1157–65.

    Article  PubMed  CAS  Google Scholar 

  • Reust CE. Common adverse effects of antiretroviral therapy for HIV disease. Am Fam Physician. 2011;83:1443–51.

    PubMed  Google Scholar 

  • Robertson KR, Su Z, Margolis DM, Krambrink A, Havlir DV, et al. Neurocognitive effects of treatment interruption in stable HIV-positive patients in an observational cohort. Neurology. 2010;74:1260–6.

    Article  PubMed  CAS  PubMed Central  Google Scholar 

  • Robertson K, Liner J, Meeker RB. Antiretroviral neurotoxicity. J Neurovirol. 2012;18:388–99.

    Article  PubMed  CAS  PubMed Central  Google Scholar 

  • Schweinsburg BC, Taylor MJ, Alhassoon OM, Gonzalez R, Brown GG, et al. Brain mitochondrial injury in human immunodeficiency virus-seropositive (HIV+) individuals taking nucleoside reverse transcriptase inhibitors. J Neurovirol. 2005;11:356–64.

    Article  PubMed  CAS  Google Scholar 

  • Thompson MA, Aberg JA, Hoy JF, Telenti A, Benson C, et al. Antiretroviral treatment of adult HIV infection: 2012 recommendations of the International Antiviral Society-USA panel. JAMA. 2012;308:387–402.

    PubMed  CAS  Google Scholar 

  • Tovar-y-Romo LB, Bumpus NN, Pomerantz D, Avery LB, Sacktor N, et al. Dendritic spine injury induced by the 8-hydroxy metabolite of efavirenz. J Pharmacol Exp Ther. 2012;343:696–703.

    Article  PubMed  CAS  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Rick B. Meeker .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2014 Springer Science+Business Media New York

About this entry

Cite this entry

Meeker, R.B., Robertson, K., Power, C. (2014). Neurotoxic Consequences of Antiretroviral Therapies. In: Hope, T., Stevenson, M., Richman, D. (eds) Encyclopedia of AIDS. Springer, New York, NY. https://doi.org/10.1007/978-1-4614-9610-6_223-1

Download citation

  • DOI: https://doi.org/10.1007/978-1-4614-9610-6_223-1

  • Received:

  • Accepted:

  • Published:

  • Publisher Name: Springer, New York, NY

  • Online ISBN: 978-1-4614-9610-6

  • eBook Packages: Springer Reference MedicineReference Module Medicine

Publish with us

Policies and ethics